Now showing items 21-40 of 54

    • Estrogen Receptors and Methods of Use 

      Wang, Zhao-Y (United States Patent Office, 2012-09-11)
      The present invention provides isolated polypeptides having an amino acid sequence having at least 70% identity to SEQ ID NO:20, wherein the polypeptide has ER-a36 activity. The invention further provides methods for ...
    • Estrogen Receptors and Methods of Use 

      Wang, Zhao-Yi (United States Patent Office, 2013-08-20)
      The present invention provides isolated polypeptides having an amino acid sequence having at least 70% identity to SEQ ID NO:20, wherein the polypeptide has ER-a36 activity. The invention further provides methods for ...
    • Estrogen Receptors and Methods of Use 

      Wang, Zhao-Yi (United States Patent Office, 2013-10-08)
      The present invention provides isolated polypeptides having an amino acid sequence having at least 70% identity to SEQ ID NO:20, wherein the polypeptide has ER-a36 activity. The invention further provides methods for ...
    • Multiplex PCR for the Detection of AmpC Beta-Lactamase Genes 

      Hanson, Nancy D.; Perez, Francisco-Javier P. (United States Patent Office, 2006-05-16)
      Oliognucleotide primers are provided that are specific for nucleic acid characteristic of certain AmpC beta-lactamases. The primers can be employed in methods to detect the presence or absence of an AmpC beta-lactamase ...
    • Compositions Derived from Modiolus Modiolus and Methods for Making and Using Same 

      Collin, Peter D.; Adrian, Thomas E. (United States Patent Office, 2008-06-17)
      Disclosed are compositions which include an isolated soft tissue from Modiolus modiolus (“MM”) and compositions which include an oil isolated from MM or a portion thereof. Also disclosed are methods of treating adenocarcinoma ...
    • Device and Method for Detecting Antibiotic Inactivating Enzymes 

      Black, Jennifer A.; Moland, Ellen Smith; Thomson, Kenneth S. (United States Patent Office, 2007-01-23)
      The present invention provides a method of determining the antibiotic susceptibility of a microorganism comprising the following steps. First, a culture of the microorganism whose susceptibility is to be determined is ...
    • Device and Method for Determining Antibiotic Susceptibility 

      Black, Jennifer A.; Moland, Ellen Smith; Thomson, Kenneth S. (United States Patent Office, 2008-02-26)
      The present invention provides a method of determining the antibiotic susceptibility of a microorganism comprising the following steps. First, a culture of the microorganism whose susceptibility is to be determined is ...
    • Use of Hydrogen Sulfide in the Treatment of Eye Diseases 

      Ohia, Sunny E.; Opere, Catherine A.; Zhan, Guilin; Monjok, Emmanuel; Kulkami, Kaustubh; Kouamou, Ghislaine E. (United States Patent Office, 2012-01-10)
      Topical administration of a generator of H2S in biological tissues for the treatment of eye disorders, such as glaucoma. NaHS caused a time-dependent decrease in intraocular pressure in normotensive, conscious albino rabbits ...
    • Cerebrospinal Fluid Collection Tubes and Methods 

      Kizer, Robert; Gross, Stephen M. (United States Patent Office, 2012-07-31)
      A cerebrospinal fluid (“CSF”) collection tube includes a bottom end portion and a tubular sidewall portion. The tubular sidewall portion has a first end and a second end, the first end being sealed to the bottom end portion ...
    • Calendar System 

      Holzapfel, Damien; Zimmerman, Stuart; Martin, Tadd (United States Patent Office, 2012-02-28)
      A calendar system displays event data via an electronic calendar form that is accessible over a network by a user of a client computer. The system stores event data for multiple events and selectively displays event data ...
    • Multiplex PCR for the Detection of AMPC Beta-Lactamase Genes 

      Hanson, Nancy D.; Perez, Francisco-Javier P. (United States Patent Office, 2009-04-21)
      Oliognucleotide primers are provided that are specific for nucleic acid characteristic of certain AmpC beta-lactamases. The primers can be employed in methods to detect the presence or absence of an AmpC beta-lactamase ...
    • Primers for Use in Detecting Beta-Lactamases 

      Hanson, Nancy D.; Sanders, Christine C.; Ehrhardt, Anton F. (United States Patent Office, 2009-01-13)
      Oliognucleotide primers are provided that are specific for nucleic acid characteristic of certain beta-lactamases. The primers can be employed in methods to identify nucleic acid characteristic of family-specific beta-lactamase ...
    • Device and Method for Detecting Antibiotic Inactivating Enzymes 

      Black, Jennifer A.; Moland, Ellen Smith; Thomson, Kenneth S. (United States Patent Office, 2008-11-18)
      The present invention provides a method of detecting production of antibiotic-inactivating factor and for determining the antibiotic susceptibility of a microorganism comprising the following steps, a culture of the ...
    • Device and Direct Method for Detecting Antibiotic-Inactivating Factors 

      Black, Jennifer A.; Moland, Ellen Smith; Thomson, Kenneth S. (United States Patent Office, 2010-05-18)
      The present invention provides a method of determining the antibiotic susceptibility of a microorganism comprising the following steps. First, a culture of the microorganism whose susceptibility is to be determined is ...
    • Device and Direct Method for Detection of Antibiotic-Inactivating Enzymes 

      Black, Jennifer A.; Thomson, Kenneth S. (United States Patent Office, 2010-10-05)
      A method for determining whether a microorganism produces an AmpC B-lactamase is disclosed in which a culture of a microorganism suspected of producing a B-lactamase that inactivates a B-lactam-containing antibiotic is ...
    • Device and Method for Detecting Antibiotic Inactivating Enzymes 

      Black, Jennifer A.; Moland, Ellen Smith; Thomson, Kenneth S. (United States Patent Office, 2007-09-11)
      The present invention provides a method of determining the antibiotic susceptibility of a microorganism comprising the following steps. First, a culture of the microorganism whose susceptibility is to be determined is ...
    • Methods for Inhibiting CGRP Binding 

      Smith, D. David; Saha, Shankar; Abel, Peter W. (United States Patent Office, 2004-06-29)
      This invention relates to antagonists of calcitonin gene related peptide and in particular the invention relates to amino terminal modifications to peptides to improve their ability to bind to a member of the CGRP-receptor ...
    • Peptide Antagonists of CGRP-Receptor Superfamily and Methods of Use 

      Smith, D. David; Shankar, Saha; Abel, Peter W. (United States Patent Office, 2001-07-31)
      This invention relates to antagonists of calcitonin gene related peptide and in particular the invention relates to amino terminal modifications to peptides to improve their ability to bind to a member of the CGRP-receptor ...
    • Method for Treating Neurocardiogenic Syncope 

      Kadri, Nazih N. (United States Patent Office, 1998-01-13)
      The present invention relates to methods for treating neu- rocardiogenic syncope. The method involves administering to a patient an effective amount of a compound having the formula: [See attached Patent Form for ...
    • High Bone Mass Gene of 11Q13.3 

      Carulli, John P.; Little, Randall D.; Recker, Robert R.; Johnson, Mark L. (United States Patent Office, 2004-08-03)
      The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, ...